ROCKVILLE, Md., Aug. 17, 2006 (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF), a biotechnology company specializing in developing and licensing systems for the treatment of non-healing chronic wounds including diabetic ulcers, today announced that Chairman and Chief Executive Officer Kshitij Mohan, Ph. D., will be the subject of an exclusive interview live on Market News First on Friday, August 18, at 10:30 a.m. Eastern time.
